Identification and characterization of novel estrogen receptor-β-sparing antiprogestins

Endocrinology

Volumn 143, Issue 8, 2002, Pages 3071-3082

  Sathya, Ganesan ^a   Jansen, Michelle S ^a   Nagel, Susan C ^a   Edgar Cook, C ^b   McDonnell, Donald P ^a,c  

^a DUKE UNIVERSITY   (United States)

^b RTI INTERNATIONAL   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; ANTIGESTAGEN; CELL NUCLEUS RECEPTOR; ESTROGEN; ESTROGEN RECEPTOR BETA; GLUCOCORTICOID RECEPTOR; ISOPROTEIN; METRIBOLONE; MIFEPRISTONE; MINERALOCORTICOID RECEPTOR; PEPTIDE DERIVATIVE; PROGESTERONE; RTI 6413 001; RTI 6413 002; RTI 6413 003; RTI 6413 006; RTI 6413 009A; RTI 6413 013; RTI 6413 015; RTI 6413 016; RTI 6413 018; RTI 6413 028; RTI 6413 029E; RTI 6413 029Z; RTI 6413 030; RTI 6413 031; RTI 6413 039; RTI 6413 042; RTI 6413 043; RTI 6413 043OX; RTI 6413 049A; STEROID HORMONE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL POPULATION; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; DRUG SELECTIVITY; FEMALE; FEMALE GENITAL SYSTEM; GENETIC TRANSCRIPTION; HORMONE ACTION; HORMONE RECEPTOR INTERACTION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUPEROVULATION;

EID: 0036327965     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.143.8.8942     Document Type: Article

References (54)

1. Progesterone receptors in reproduction: Functional impact of the A and B isoforms
2. The A and B isoforms of the human progesterone receptor: Two functionally different transcription factors encoded by a single gene
3. The A and B isoforms of the human progesterone receptor operate through district signaling pathways within target cells
4. 16α-substituted anologs of the antiprogestin RU486 induce a unique conformation in the human progesterone receptor resulting in mixed agonist activity
5. Human progesterone receptor A form is a cell- and promoter-specific repressor of human progesterone receptor B function
6. The opposing transcriptional activities of the two isoforms of the human progesterone receptor are due to differential cofactor binding
7. Nuclear receptor coactivators and corepressors
8. Coactivators and corepressors as mediators of nuclear receptor function: An update
9. Estrogen receptor β activates the human retinoic acid receptor α-1 promoter in response to tamoxifen and other estrogen receptor antagonists, but not in response to estrogen
10. Mifepristone (RU486) - A modulator of progestin and glucocorticoid action
11. Androgen-like and anti-androgen-like effects of antiprogestins in human mammary cancer cells
12. The human progesterone receptor A-form functions as a transcriptional modulator of mineralocorticoid receptor transcriptional activity
13. RU486 exerts antiestrogenic activities through a novel progesterone receptor A form-mediated mechanism
14. Estrogenic effects of the antiprogestin onapristone (ZK98.299) in the rodent uterus
15. Antiprogestins and iatrogenic glucocorticoid resistance
16. Contragestation and other clinical applications of RU486, an antiprogesterone at the receptor
17. Treatment of breast cancer with different antiprogestins: Preclinical and clinical studies
18. Progestational agents in advanced breast cancer: An overview
19. Steroid hormone receptors in human meningiomas, gliomas and brain metastases
20. Endocrine responses to long-term administration of the antiprogesterone RU486 in patients with pelvic endometriosis
21. Progesterone antagonists and progesterone receptor modulators in the treatment of breast cancer
22. The mechanism of RU486 antagonism is dependent on the conformation of the carboxy-terminal tail of the human progesterone receptor
23. History and perspectives of antiprogestins from the chemist's point of view
24. Effects of D-ring substituents on antiprogestational (antagonist) and progestational (agonist) activity of 11 β-aryl steroids
25. Reversal of activity profile in analogs of the antiprogestin RU 486: Effect of a 16 α-substituent on progestational (agonist) activity
26. The novel progesterone receptor antagonists RTI 3021-012 and RTI 3021-022 exhibit complex glucocorticoid receptor antagonist activities: Implications for the development of dissociated antiprogestins
27. Effect of a 17α-(3-hydroxypropyl)-17β-acetyl substituent pattern on the glucocorticoid and progestin receptor binding of 11β-arylestra-4, 9-dien-3-ones
28. Mapping and characterization of the functional domains responsible for the differential activity of the A and B isoforms of the human progesterone receptor
29. The estrogen receptor β-isoform (ERβ) of the human estrogen receptor modulates ERα transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens
30. Human estrogen receptor transactivational capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regions
31. Dissection of the LXXLL nuclear receptor-coactivator interaction motif using combinatorial peptide libraries: Discovery of peptide antagonists of estrogen receptors α and β
32. Development of peptide antagonists that target estrogen receptor β-coactivator interactions
33. Peptide antagonists of the human estrogen receptor
34. Identification of a new subclass of Alu DNA repeats which can function as estrogen receptor-dependent transcriptional enhancers
35. Effects of anti-progesterone compound RU486 on ovulation in immature mice treated with PMSG/hCG
36. Estrogen receptor (ER) modulators each induce distinct conformational changes in ERα and ERβ
37. Selective estrogen receptor modulators (SERMs): A first step in the development of perfect hormone replacement therapy regimen
38. Development of peptide antagonists that target estrogen receptor-cofactor interactions
39. Nuclear receptor coregulators: Cellular and molecular biology
40. Analysis of estrogen receptor function in vitro reveals three distinct classes of antiestrogens
41. Preovulatory effects of the progesterone antagonist mifepristone (RU486) in mice
42. Hormone induction of progesterone receptor (PR) messenger ribonucleic acid and activation of PR promoter regions in ovarian granulosa cells: Evidence for a role of cyclic adenosine 3′, 5′-monophosphate but not estradiol
43. Reproductive functions of the progesterone receptor
44. Reproductive functions of the progesterone receptor isoforms: Lessons from knock-out mice
45. Subgroup of reproductive functions of progesterone mediated by progesterone receptor-B isoform
46. Progestin and antiprogestin effects on progesterone receptor transformation
47. New antiprogestins with partial agonist activity: Potential selective progesterone receptor modulators (SPRMs) and probes for receptor- and coregulator-induced changes in progesterone receptor induction properties
48. Differential gene regulation by the two progesterone receptor isoforms in human breast cancer cells
49. Progesterone receptor coactivators
50. The nuclear corepressors NCoR and SMRT are key regulators of both ligand- and 8-bromo-cydic AMP-dependent transcriptional activity of the human progesterone receptor
51. The partial agonist activity of antagonist-occupied steroid receptors is controlled by a novel hinge domain-binding coactivator L7/SPA and the corepressors N-CoR or SMRT